STAT3 operates as an inflammation-dependent transcriptional switch in antiviral NK cells
Science Immunology · 2026
DOI: 10.1126/sciimmunol.aed4832 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, 2026. Verfasst von Simon Grassmann und 11 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Hauptthemen laut MEDLINE: Killer Cells, Natural, STAT3 Transcription Factor, Muromegalovirus, Inflammation. Die Arbeit nennt 65 Literaturangaben. Gefördert von: National Institutes of Health, Cancer Center, University of Florida Health, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
The immune system integrates signals to regulate immune responses, forming complex context-dependent networks where identical cues produce distinct outcomes. Signal transducer and activator of transcription (STAT) transcription factors convert cytokine receptor engagement into transcriptional responses, serving as central regulatory hubs. How concurrent STAT activation across different environments shapes immune cell function remains unclear. Here, we show that STAT3 plays a context-dependent role in antiviral natural killer (NK) cells, either promoting or impairing adaptive responses depending on the inflammatory milieu during mouse cytomegalovirus (MCMV) infection. STAT3 is recruited to distinct genomic loci depending on IL-15 or type I interferon availability, thus driving alternative transcriptional programs. Mechanistically, STAT3 differentially regulates downstream transcription factors MYB and B lymphocyte–induced maturation protein-1 (BLIMP-1) to shape NK cell differentiation during homeostasis and infection. STAT3 relocation is governed by epigenetic mechanisms and preferred relocation toward distinct STAT motifs. Thus, STAT3 functions as a cytokine-sensing transcriptional switch integrating IL-15 and type I interferon signals to control lymphocyte adaptation during viral infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- Charité-Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin and Humboldt-Universitaet zu Berlin, Institute of Medical Immunology, Berlin, Germany.
- Wuerzburg Institute of Systems Immunology (WueSI), Max Planck Research Group at the Julius-Maximilians-Universitaet Wuerzburg, Wuerzburg, Germany.
- Division of Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
- Immunology and Microbial Pathogenesis Program, Weill Cornell Medical College, New York, NY, USA.
ORCID-Profile: Simon Grassmann, Hyunu Kim, Timo Rückert, Christin Friedrich, Marine Pujol, Sherry X Fan, Mark Owyong, Jennifer M Zhang, Veit R Buchholz, Georg Gasteiger, Joseph C Sun
Förderung
- National Institutes of Health
- Cancer Center, University of Florida Health
- Deutsche Forschungsgemeinschaft
- Korea Hydro and Nuclear Power Central Research Institute
- Integrated Genomics Operation Core RRID SCR_
Zitieren
APA
Grassmann, S., Kim, H., Rückert, T., Friedrich, C., Pujol, M., Fan, S. X., Owyong, M., Zhang, J. M., Beroshvili, G., Buchholz, V. R., Gasteiger, G., & Sun, J. C. (2026). STAT3 operates as an inflammation-dependent transcriptional switch in antiviral NK cells. Science Immunology. https://doi.org/10.1126/sciimmunol.aed4832
Vancouver
Grassmann S, Kim H, Rückert T, Friedrich C, Pujol M, Fan SX, et al. STAT3 operates as an inflammation-dependent transcriptional switch in antiviral NK cells. Science Immunology. 2026. doi:10.1126/sciimmunol.aed4832
BibTeX
@article{Grassmann2026,
author = {Grassmann, Simon and Kim, Hyunu and Rückert, Timo and Friedrich, Christin and Pujol, Marine and Fan, Sherry X and Owyong, Mark and Zhang, Jennifer M and Beroshvili, Giorgi and Buchholz, Veit R and Gasteiger, Georg and Sun, Joseph C},
title = {STAT3 operates as an inflammation-dependent transcriptional switch in antiviral NK cells},
journal = {Science Immunology},
year = {2026},
doi = {10.1126/sciimmunol.aed4832}
}
EUVIMED